Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Association of preprocedural low-density lipoprotein cholesterol levels with myocardial injury after elective percutaneous coronary intervention.

Li XL, Li JJ, Guo YL, Zhu CG, Xu RX, Li S, Qing P, Wu NQ, Jiang LX, Xu B, Gao RL.

J Clin Lipidol. 2014 Jul-Aug;8(4):423-32. doi: 10.1016/j.jacl.2014.04.002. Epub 2014 Apr 15.

PMID:
25110224
2.
3.

Non-HDL cholesterol is a better target for predicting periprocedural myocardial injury following percutaneous coronary intervention in type 2 diabetes.

Zeng RX, Li XL, Zhang MZ, Guo YL, Zhu CG, Guo LH, Li S, Zhang Y, Li JJ.

Atherosclerosis. 2014 Dec;237(2):536-43. doi: 10.1016/j.atherosclerosis.2014.10.030. Epub 2014 Oct 22.

PMID:
25463086
4.

Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.

Zeng RX, Li XL, Zhang MZ, Wang XW, Guo YL, Zhu CG, Ren Y, Li S, Zhang Y, Liu G, Xu RX, Dong Q, Li JJ.

Scand J Clin Lab Invest. 2015 Nov;75(7):568-77. doi: 10.3109/00365513.2015.1060518. Epub 2015 Jul 30.

PMID:
26203960
5.

The ratio of high-density lipoprotein cholesterol to apolipoprotein A-I predicts myocardial injury following elective percutaneous coronary intervention.

Li XL, Li JJ, Guo YL, Zhu CG, Qing P, Wu NQ, Xu B, Gao RL.

Clin Cardiol. 2014 Sep;37(9):558-65. doi: 10.1002/clc.22308. Epub 2014 Aug 11.

6.

Relationship of glycated hemoglobin levels with myocardial injury following elective percutaneous coronary intervention in patients with type 2 diabetes mellitus.

Li XL, Li JJ, Guo YL, Zhu CG, Xu RX, Li S, Qing P, Wu NQ, Jiang LX, Xu B, Gao RL.

PLoS One. 2014 Jul 2;9(7):e101719. doi: 10.1371/journal.pone.0101719. eCollection 2014.

7.

Impact of increased admission lipid levels on periprocedural myocardial injury following an elective percutaneous coronary intervention.

Buturak A, Degirmencioglu A, Erturk M, Karakurt H, Demir AR, Surgit O, Pusuroglu H, Akgul O, Serteser M, Norgaz T, Gorgulu S.

Coron Artery Dis. 2015 Jun;26(4):333-40. doi: 10.1097/MCA.0000000000000235.

PMID:
25714068
8.

Remnant cholesterol predicts periprocedural myocardial injury following percutaneous coronary intervention in poorly-controlled type 2 diabetes.

Zeng RX, Li S, Zhang MZ, Li XL, Zhu CG, Guo YL, Zhang Y, Li JJ.

J Cardiol. 2017 Aug;70(2):113-120. doi: 10.1016/j.jjcc.2016.12.010. Epub 2017 Feb 13.

PMID:
28209463
9.

High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.

Sattler KJ, Herrmann J, Yün S, Lehmann N, Wang Z, Heusch G, Sack S, Erbel R, Levkau B.

Eur Heart J. 2009 Aug;30(15):1894-902. doi: 10.1093/eurheartj/ehp183. Epub 2009 May 27.

PMID:
19474052
10.

Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.

Gordin J, Haider A, Swaminathan RV, Kim LK, Minutello RM, Bergman G, Wong SC, Feldman DN.

Am J Cardiol. 2012 Nov 15;110(10):1397-404. doi: 10.1016/j.amjcard.2012.06.052. Epub 2012 Aug 2.

PMID:
22858186
11.

Relationship between subclinical cardiac troponin I elevation and culprit lesion characteristics assessed by optical coherence tomography in patients undergoing elective percutaneous coronary intervention.

Lee T, Murai T, Yonetsu T, Suzuki A, Hishikari K, Kanaji Y, Matsuda J, Araki M, Niida T, Isobe M, Kakuta T.

Circ Cardiovasc Interv. 2015 Apr;8(4). pii: e001727. doi: 10.1161/CIRCINTERVENTIONS.114.001727.

12.

LDL cholesterol as a novel risk factor for contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention.

Liu YH, Liu Y, Chen JY, Zhou YL, Chen ZJ, Yu DQ, Luo JF, Li HL, He YT, Ye P, Ran P, Guo W, Tan N.

Atherosclerosis. 2014 Dec;237(2):453-9. doi: 10.1016/j.atherosclerosis.2014.10.022. Epub 2014 Oct 17.

PMID:
25463073
13.

Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.

Napan S, Kashinath RC, Kadri S, Orig MN, Khadra S.

Coron Artery Dis. 2010 Aug;21(5):261-5. doi: 10.1097/MCA.0b013e32833aa6fa.

PMID:
20555264
14.

Defining the optimal cardiac troponin T threshold for predicting death caused by periprocedural myocardial infarction after percutaneous coronary intervention.

Herrmann J, Lennon RJ, Jaffe AS, Holmes DR Jr, Rihal CS, Prasad A.

Circ Cardiovasc Interv. 2014 Aug;7(4):533-42. doi: 10.1161/CIRCINTERVENTIONS.113.000544. Epub 2014 Jul 22.

15.

Elective percutaneous coronary intervention: the relationship between preprocedural blood glucose levels and periprocedural myocardial injury.

Madani M, Alizadeh K, Ghazaee SP, Zavarehee A, Abdi S, Shakerian F, Salehi N, Firouzi A.

Tex Heart Inst J. 2013;40(4):410-7.

16.

Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.

Verdoia M, Schaffer A, Barbieri L, Di Giovine G, Marino P, De Luca G; Novara Atherosclerosis Study Group (NAS).

Diabetes Metab Res Rev. 2014 May;30(4):297-304.

PMID:
24829966
17.

Effects of polyunsaturated fatty acids on periprocedural myocardial infarction after elective percutaneous coronary intervention.

Suzuki A, Ando H, Takashima H, Kumagai S, Kurita A, Waseda K, Suzuki Y, Mizuno T, Harada K, Uetani T, Takahashi H, Yoshikawa D, Ishii H, Murohara T, Amano T.

EuroIntervention. 2014 Nov;10(7):792-8. doi: 10.4244/EIJV10I7A138.

18.

The prognostic value of very low admission LDL-cholesterol levels in ST-segment elevation myocardial infarction compared in statin-pretreated and statin-naive patients undergoing primary percutaneous coronary intervention.

Oduncu V, Erkol A, Kurt M, Tanboğa IH, Karabay CY, Şengül C, Bulut M, Özveren O, Fotbolcu H, Akgün T, Türkyilmaz E, Kırma C.

Int J Cardiol. 2013 Jul 31;167(2):458-63. doi: 10.1016/j.ijcard.2012.01.009. Epub 2012 Feb 2.

PMID:
22305817
19.
20.

Prognostic value of cardiac troponin I elevation after percutaneous coronary intervention in patients with chronic renal insufficiency: a 12-month outcome analysis.

Gruberg L, Fuchs S, Waksman R, Pichard AD, Kent KM, Laird JR, Wu H, Elsayyad S, Allen CM, Satler LF.

Catheter Cardiovasc Interv. 2002 Feb;55(2):174-9.

PMID:
11835642

Supplemental Content

Support Center